RT Book, Section
A1 Villalon, Mark L.
A1 Nedeljkovic, Zoran S.
A1 Jacobs, Alice K.
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146599912
T1 Special Patient Subset: Diabetes Mellitus
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146599912
RD 2024/04/23
AB Diabetes  mellitus  affects  a  significant  portion  of  the  population;  1  in  10  adults  in  the  United  States  has  diabetes,  with  90%  to  95%  of  patients  having  type  2  diabetes.1  In  2012,  nearly  20.1  million  Americans  ≥20  years  of  age  were  diagnosed  with  diabetes  mellitus,  8.1  million  Americans  had  undiagnosed  diabetes  mellitus,  and  an  estimated  80.8  million  (35.3%)  had  prediabetes  (ie,  fasting  blood  glucose  of  100  to  <126  mg/dL).1  The  prevalence  of  diabetes  mellitus  is  rapidly  increasing  and  is  attributed  to  the  increased  frequency  of  obesity,  suboptimal  nutritional  habits,  and  aging  of  the  population  (Fig.  40-1).2  The  total  prevalence  of  diabetes  mellitus  in  the  United  States  is  expected  to  more  than  double  from  2005  to  2050  (from  5.6%  to  12.0%)  in  all  age,  sex,  and  race/ethnicity  groups,  with  minorities  disproportionately  affected.1  This  increase,  however,  is  not  limited  to  the  United  States.  The  global  prevalence  of  diabetes  mellitus  for  all  age  groups  is  also  increasing.  In  2010,  the  prevalence  of  diabetes  mellitus  worldwide  was  estimated  to  be  6.4%  and  is  projected  to  increase  to  7.7%  in  2030;  the  total  number  of  people  with  diabetes  mellitus  is  projected  to  increase  from  285  million  in  2010  to  439  million  in  2030.1,3